ArticleCureus2025
Role of Adjuvant Radiotherapy in Sweat Gland Carcinoma: A Case Report and Literature Review.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- S1 guideline sweat gland carcinoma.Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG · 2026Guideline
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sweat gland carcinoma (SGC) is a rare type of malignant adnexal tumours of the skin (MATS). It has potential for local infiltration, regional nodal involvement, and distant metastasis. Wide local excision with regional lymph nodal dissection is the mainstay of treatment and there are no consensus guidelines for adjuvant treatment. We present a case report of a gentleman, suffering from SGC in the left lumbar region with axillary nodal metastasis, presenting with a longstanding skin nodule, with recent spurt in growth and ulceration over it. He was treated with wide local excision of the lesion and left axillary nodal dissection. Postoperative histopathology and immunohistochemistry confirmed the diagnosis of SGC. He received adjuvant radiotherapy to primary and nodal sites due to the presence of high-risk features. Diagnosis of SGC is very challenging due to clinical variation, nonspecific immunohistochemistry profile, and histopathological surprises. Due to the paucity of relevant literature, the role of adjuvant radiotherapy is still not established, but in view of the aggressive behaviour of SGC, radiotherapy significantly improves local and regional control, particularly in the presence of high-risk pathological features. Further studies in the domain of adjuvant treatment of SGC is needed to improve disease outcomes optimally.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.